Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes.
- Published In:
- European journal of pharmacology, 872, 172971 (2020)
- Authors:
- Can, Vedia C, Locke, Ian C, Kaneva, Magdalena K, Kerrigan, Mark J P, Merlino, Francesco, De Pascale, Clara, Grieco, Paolo, Getting, Stephen J
- Database ID:
- RPEP-04689
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04689APA
Can, Vedia C; Locke, Ian C; Kaneva, Magdalena K; Kerrigan, Mark J P; Merlino, Francesco; De Pascale, Clara; Grieco, Paolo; Getting, Stephen J. (2020). Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes.. European journal of pharmacology, 872, 172971. https://doi.org/10.1016/j.ejphar.2020.172971
MLA
Can, Vedia C, et al. "Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes.." European journal of pharmacology, 2020. https://doi.org/10.1016/j.ejphar.2020.172971
RethinkPeptides
RethinkPeptides Research Database. "Novel anti-inflammatory and chondroprotective effects of the..." RPEP-04689. Retrieved from https://rethinkpeptides.com/research/can-2020-novel-antiinflammatory-and-chondroprotective
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.